Thalidomide reduces serum C-reactive protein and interleukin-6 and induces response to IL-2 in a fraction of metastatic renal cell cancer patients who failed IL-2-based therapy (Q44834251)
Jump to navigation
Jump to search
scientific article published in June 2004
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Thalidomide reduces serum C-reactive protein and interleukin-6 and induces response to IL-2 in a fraction of metastatic renal cell cancer patients who failed IL-2-based therapy |
scientific article published in June 2004 |
Statements
1 reference
Thalidomide reduces serum C-reactive protein and interleukin-6 and induces response to IL-2 in a fraction of metastatic renal cell cancer patients who failed IL-2-based therapy (English)
1 reference
Igal Kedar
1 reference
Wilmosh Mermershtain
1 reference
Hefziba Ivgi
1 reference
1 June 2004
1 reference
1 reference
Identifiers
1 reference